GFM
NBP

GF Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

GF Fund Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.63K Buy
2,377
+56
+2% +$114 ﹤0.01% 573
2026
Q1 		$5.71K Buy
2,321
+279
+14% +$934 ﹤0.01% 600
2025
Q4 		$8.13K Buy
+2,042
New +$9.04K ﹤0.01% 596

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GF Fund Management's NBP Position: Q2 2026 in Review

GF Fund Management increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 2.4% in Q2 2026, buying an estimated $114 and bringing the position to 2,377 shares worth $4.63K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

GF Fund Management first reported a position in NBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.13K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • GF Fund Management held 2,377 shares of NovaBridge Biosciences American Depositary Shares worth $4.63K as of Q2 2026.
  • GF Fund Management bought 56 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $114.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #573 holding.
  • GF Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $8.13K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.